Acceptability and Validity of the EQ-5D in Patients Living With Dementia
To assess the acceptability and validity of the 3 levels of the EQ-5D (EQ-5D-3L) compared with the Quality of Life in Alzheimer’s Diseases (QoL-AD) in patients living with dementia. The analysis was based on 560 dyads of persons with dementia and their caregivers of the multicenter observational stu...
Uložené v:
| Vydané v: | Value in health Ročník 23; číslo 6; s. 760 - 767 |
|---|---|
| Hlavní autori: | , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
Lawrenceville
Elsevier Inc
01.06.2020
Elsevier Science Ltd |
| Predmet: | |
| ISSN: | 1098-3015, 1524-4733, 1524-4733 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
| Abstract | To assess the acceptability and validity of the 3 levels of the EQ-5D (EQ-5D-3L) compared with the Quality of Life in Alzheimer’s Diseases (QoL-AD) in patients living with dementia.
The analysis was based on 560 dyads of persons with dementia and their caregivers of the multicenter observational study of dementia care networks in Germany (DemNet-D). Health-related quality of life was assessed by face-to-face interviews using the EQ-5D-3L (self-rating) and the QoL-AD (self- and proxy-rating). The number of missing values, the score ranges (observed vs possible range) and the floor and ceiling effects were used to assess the acceptability. We used one-way analyses of variance and multivariate linear regression models to evaluate the discriminative ability. The convergent validity was assessed using Spearman's correlation coefficient (rs) and multivariate regression models.
The EQ-5D index had a higher response rate (89% vs 84%) and a comparable floor (>1%) but a higher ceiling effect (18% vs >1%) compared with the QoL-AD. Both measures can significantly differentiate between different stages of general health, instrumental activities of daily living, and depression. The EQ-5D index and the visual analog scale self-rating scores strongly correlated with the QoL-AD self-rating (rs = 0.644 and 0.553, respectively) but not with the proxy-rating score (rs = 0.314 and rs = 0.170, respectively), which was confirmed by multivariate regression analyses.
The results satisfy acceptability, discriminative ability, and convergent validity for moderately cognitively and functionally impaired patients living with dementia. The EQ-5D-3L performed comparably with the QoL-AD, and could, therefore, be used in economic evaluations in dementia. The differences between self- and proxy-ratings should be evaluated and considered in the interpretation of health-related quality of life scores. |
|---|---|
| AbstractList | Objectives To assess the acceptability and validity of the 3 levels of the EQ-5D (EQ-5D-3L) compared with the Quality of Life in Alzheimer's Diseases (QoL-AD) in patients living with dementia. Methods The analysis was based on 560 dyads of persons with dementia and their caregivers of the multicenter observational study of dementia care networks in Germany (DemNet-D). Health-related quality of life was assessed by face-to-face interviews using the EQ-5D-3L (self-rating) and the QoL-AD (self- and proxy-rating). The number of missing values, the score ranges (observed vs possible range) and the floor and ceiling effects were used to assess the acceptability. We used one-way analyses of variance and multivariate linear regression models to evaluate the discriminative ability. The convergent validity was assessed using Spearman's correlation coefficient (rs) and multivariate regression models. Results The EQ-5D index had a higher response rate (89% vs 84%) and a comparable floor (>1%) but a higher ceiling effect (18% vs >1%) compared with the QoL-AD. Both measures can significantly differentiate between different stages of general health, instrumental activities of daily living, and depression. The EQ-5D index and the visual analog scale self-rating scores strongly correlated with the QoL-AD self-rating (rs = 0.644 and 0.553, respectively) but not with the proxy-rating score (rs = 0.314 and rs = 0.170, respectively), which was confirmed by multivariate regression analyses. Conclusion The results satisfy acceptability, discriminative ability, and convergent validity for moderately cognitively and functionally impaired patients living with dementia. The EQ-5D-3L performed comparably with the QoL-AD, and could, therefore, be used in economic evaluations in dementia. The differences between self- and proxy-ratings should be evaluated and considered in the interpretation of health-related quality of life scores. To assess the acceptability and validity of the 3 levels of the EQ-5D (EQ-5D-3L) compared with the Quality of Life in Alzheimer’s Diseases (QoL-AD) in patients living with dementia. The analysis was based on 560 dyads of persons with dementia and their caregivers of the multicenter observational study of dementia care networks in Germany (DemNet-D). Health-related quality of life was assessed by face-to-face interviews using the EQ-5D-3L (self-rating) and the QoL-AD (self- and proxy-rating). The number of missing values, the score ranges (observed vs possible range) and the floor and ceiling effects were used to assess the acceptability. We used one-way analyses of variance and multivariate linear regression models to evaluate the discriminative ability. The convergent validity was assessed using Spearman's correlation coefficient (rs) and multivariate regression models. The EQ-5D index had a higher response rate (89% vs 84%) and a comparable floor (>1%) but a higher ceiling effect (18% vs >1%) compared with the QoL-AD. Both measures can significantly differentiate between different stages of general health, instrumental activities of daily living, and depression. The EQ-5D index and the visual analog scale self-rating scores strongly correlated with the QoL-AD self-rating (rs = 0.644 and 0.553, respectively) but not with the proxy-rating score (rs = 0.314 and rs = 0.170, respectively), which was confirmed by multivariate regression analyses. The results satisfy acceptability, discriminative ability, and convergent validity for moderately cognitively and functionally impaired patients living with dementia. The EQ-5D-3L performed comparably with the QoL-AD, and could, therefore, be used in economic evaluations in dementia. The differences between self- and proxy-ratings should be evaluated and considered in the interpretation of health-related quality of life scores. To assess the acceptability and validity of the 3 levels of the EQ-5D (EQ-5D-3L) compared with the Quality of Life in Alzheimer's Diseases (QoL-AD) in patients living with dementia.OBJECTIVESTo assess the acceptability and validity of the 3 levels of the EQ-5D (EQ-5D-3L) compared with the Quality of Life in Alzheimer's Diseases (QoL-AD) in patients living with dementia.The analysis was based on 560 dyads of persons with dementia and their caregivers of the multicenter observational study of dementia care networks in Germany (DemNet-D). Health-related quality of life was assessed by face-to-face interviews using the EQ-5D-3L (self-rating) and the QoL-AD (self- and proxy-rating). The number of missing values, the score ranges (observed vs possible range) and the floor and ceiling effects were used to assess the acceptability. We used one-way analyses of variance and multivariate linear regression models to evaluate the discriminative ability. The convergent validity was assessed using Spearman's correlation coefficient (rs) and multivariate regression models.METHODSThe analysis was based on 560 dyads of persons with dementia and their caregivers of the multicenter observational study of dementia care networks in Germany (DemNet-D). Health-related quality of life was assessed by face-to-face interviews using the EQ-5D-3L (self-rating) and the QoL-AD (self- and proxy-rating). The number of missing values, the score ranges (observed vs possible range) and the floor and ceiling effects were used to assess the acceptability. We used one-way analyses of variance and multivariate linear regression models to evaluate the discriminative ability. The convergent validity was assessed using Spearman's correlation coefficient (rs) and multivariate regression models.The EQ-5D index had a higher response rate (89% vs 84%) and a comparable floor (>1%) but a higher ceiling effect (18% vs >1%) compared with the QoL-AD. Both measures can significantly differentiate between different stages of general health, instrumental activities of daily living, and depression. The EQ-5D index and the visual analog scale self-rating scores strongly correlated with the QoL-AD self-rating (rs = 0.644 and 0.553, respectively) but not with the proxy-rating score (rs = 0.314 and rs = 0.170, respectively), which was confirmed by multivariate regression analyses.RESULTSThe EQ-5D index had a higher response rate (89% vs 84%) and a comparable floor (>1%) but a higher ceiling effect (18% vs >1%) compared with the QoL-AD. Both measures can significantly differentiate between different stages of general health, instrumental activities of daily living, and depression. The EQ-5D index and the visual analog scale self-rating scores strongly correlated with the QoL-AD self-rating (rs = 0.644 and 0.553, respectively) but not with the proxy-rating score (rs = 0.314 and rs = 0.170, respectively), which was confirmed by multivariate regression analyses.The results satisfy acceptability, discriminative ability, and convergent validity for moderately cognitively and functionally impaired patients living with dementia. The EQ-5D-3L performed comparably with the QoL-AD, and could, therefore, be used in economic evaluations in dementia. The differences between self- and proxy-ratings should be evaluated and considered in the interpretation of health-related quality of life scores.CONCLUSIONThe results satisfy acceptability, discriminative ability, and convergent validity for moderately cognitively and functionally impaired patients living with dementia. The EQ-5D-3L performed comparably with the QoL-AD, and could, therefore, be used in economic evaluations in dementia. The differences between self- and proxy-ratings should be evaluated and considered in the interpretation of health-related quality of life scores. AbstractObjectivesTo assess the acceptability and validity of the 3 levels of the EQ-5D (EQ-5D-3L) compared with the Quality of Life in Alzheimer’s Diseases (QoL-AD) in patients living with dementia. MethodsThe analysis was based on 560 dyads of persons with dementia and their caregivers of the multicenter observational study of dementia care networks in Germany (DemNet-D). Health-related quality of life was assessed by face-to-face interviews using the EQ-5D-3L (self-rating) and the QoL-AD (self- and proxy-rating). The number of missing values, the score ranges (observed vs possible range) and the floor and ceiling effects were used to assess the acceptability. We used one-way analyses of variance and multivariate linear regression models to evaluate the discriminative ability. The convergent validity was assessed using Spearman's correlation coefficient ( rs) and multivariate regression models. ResultsThe EQ-5D index had a higher response rate (89% vs 84%) and a comparable floor (>1%) but a higher ceiling effect (18% vs >1%) compared with the QoL-AD. Both measures can significantly differentiate between different stages of general health, instrumental activities of daily living, and depression. The EQ-5D index and the visual analog scale self-rating scores strongly correlated with the QoL-AD self-rating ( rs = 0.644 and 0.553, respectively) but not with the proxy-rating score ( rs = 0.314 and rs = 0.170, respectively), which was confirmed by multivariate regression analyses. ConclusionThe results satisfy acceptability, discriminative ability, and convergent validity for moderately cognitively and functionally impaired patients living with dementia. The EQ-5D-3L performed comparably with the QoL-AD, and could, therefore, be used in economic evaluations in dementia. The differences between self- and proxy-ratings should be evaluated and considered in the interpretation of health-related quality of life scores. |
| Author | Xie, Feng Michalowsky, Bernhard Kohlmann, Thomas Gräske, Johannes Wübbeler, Markus Hoffmann, Wolfgang Thyrian, Jochen René |
| Author_xml | – sequence: 1 givenname: Bernhard surname: Michalowsky fullname: Michalowsky, Bernhard organization: German Center for Neurodegenerative Diseases, Rostock/Greifswald site, Greifswald, Germany – sequence: 2 givenname: Feng surname: Xie fullname: Xie, Feng email: fengxie@mcmaster.ca organization: Program for Health Economics and Outcome Measures, Hamilton, Ontario, Canada – sequence: 3 givenname: Thomas surname: Kohlmann fullname: Kohlmann, Thomas organization: Institute for Community Medicine, Section Methods in Community Medicine, University Medicine Greifswald, Greifswald, Germany – sequence: 4 givenname: Johannes surname: Gräske fullname: Gräske, Johannes organization: Alice Salomon University of Applied Sciences Berlin, Berlin, Germany – sequence: 5 givenname: Markus surname: Wübbeler fullname: Wübbeler, Markus organization: University of Applied Sciences–Bochum, Department of Nursing Science, Bochum, Germany – sequence: 6 givenname: Jochen René surname: Thyrian fullname: Thyrian, Jochen René organization: German Center for Neurodegenerative Diseases, Rostock/Greifswald site, Greifswald, Germany – sequence: 7 givenname: Wolfgang surname: Hoffmann fullname: Hoffmann, Wolfgang organization: German Center for Neurodegenerative Diseases, Rostock/Greifswald site, Greifswald, Germany |
| BookMark | eNqFkUtr3DAUhU1JoUnaP9CVoJtu7F69_CilEJI0KQy0pa-lkK-vG7keeWJpBubfR2ZKFwNNF3pyviPdc8-yEz95yrKXHAoOvHwzFMPOjoUAAQXwAoR4kp1yLVSuKilP0h6aOpfA9bPsLIQBAEop9Gl2e4FIm2hbN7q4Z9Z37IcdXbccpp7FO2LXX3J9xZxnn2105GNgK7dz_hf76eIdu6J1unP2efa0t2OgF3_W8-z7h-tvl7f56tPNx8uLVY6qrGKOZa9EqWtZIjRtpVpqBVoirPqGlzUJ1FDZjkuFtlWixbqsWm6Bp9F0Fcrz7PXBdzNP91sK0axdQBpH62naBiMUVwC10DpJXx1Jh2k7-_S7pJJSNEppnlT1QYXzFMJMvUEXU6WTj7N1o-FglojNYJaIzRKxAW5SxAkVR-hmdms77x-H3h0gSintHM0mYIoVqXMzYTTd5B7H3x_hODrv0I6_aU_hb4XcBGHAfF0av_RdwDJLlQze_tvgf68_AOVhvXo |
| CitedBy_id | crossref_primary_10_1007_s40120_022_00335_x crossref_primary_10_1111_scs_13139 crossref_primary_10_1007_s11482_023_10157_0 crossref_primary_10_1007_s10198_021_01273_5 crossref_primary_10_1007_s41669_024_00548_w crossref_primary_10_1007_s12311_023_01597_3 crossref_primary_10_1007_s40120_024_00694_7 crossref_primary_10_1186_s12955_023_02204_z crossref_primary_10_1371_journal_pone_0290606 crossref_primary_10_1016_j_jval_2024_04_010 crossref_primary_10_1186_s13561_022_00374_y crossref_primary_10_3390_brainsci11030372 crossref_primary_10_1007_s11136_022_03158_3 crossref_primary_10_1002_trc2_12383 crossref_primary_10_1186_s12955_022_02036_3 crossref_primary_10_3389_fpubh_2023_1031978 crossref_primary_10_1007_s11136_021_03007_9 crossref_primary_10_1007_s10198_023_01574_x crossref_primary_10_1007_s11136_022_03185_0 crossref_primary_10_1016_j_vhri_2025_101122 crossref_primary_10_1111_jgh_15238 crossref_primary_10_1002_wps_21338 |
| Cites_doi | 10.1007/s11136-004-1258-0 10.1097/00006842-200205000-00016 10.1016/0022-3956(82)90033-4 10.1186/s12955-018-0959-y 10.1016/j.jval.2017.09.005 10.1002/gps.1075 10.1111/j.1532-5415.2010.02790.x 10.1023/A:1008809610703 10.1186/s12877-018-0834-z 10.1007/s11136-004-1920-6 10.1007/s11136-014-0770-0 10.1093/rheumatology/36.5.551 10.1080/13607860801919850 10.1007/s11136-005-4364-8 10.1007/s11136-010-9600-1 10.1111/ggi.12108 10.1016/j.burns.2008.11.007 10.1017/S1041610205002073 10.1177/0272989X11401031 10.1017/S1041610207004863 10.1111/j.1524-4733.2010.00728.x 10.1186/s12955-017-0585-0 10.1007/s00391-017-1336-x 10.1016/j.jalz.2012.11.007 10.1016/j.jval.2010.08.002 10.1097/00002093-199206030-00001 10.1192/bjp.183.3.248 10.1002/gps.4771 10.1023/A:1014406429385 10.1017/S1041610292001157 10.1017/S1041610292001285 10.1186/1471-2288-13-110 10.1016/j.jclinepi.2015.08.002 10.1097/00002093-200310000-00002 10.1192/bjp.bp.113.137414 10.1136/bmjopen-2017-018996 10.1136/bmj.h3029 10.1007/s11136-015-1065-9 10.1007/s10198-003-0182-5 10.1017/S1041610297004869 10.1080/13607863.2014.915923 10.1016/j.jalz.2007.11.018 10.1093/geront/9.3_Part_1.179 10.1016/0168-8510(90)90421-9 |
| ContentType | Journal Article |
| Copyright | 2020 ISPOR–The Professional Society for Health Economics and Outcomes Research ISPOR–The Professional Society for Health Economics and Outcomes Research Copyright Elsevier Science Ltd. Jun 2020 Copyright © 2020 ISPOR–The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc. All rights reserved. |
| Copyright_xml | – notice: 2020 ISPOR–The Professional Society for Health Economics and Outcomes Research – notice: ISPOR–The Professional Society for Health Economics and Outcomes Research – notice: Copyright Elsevier Science Ltd. Jun 2020 – notice: Copyright © 2020 ISPOR–The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc. All rights reserved. |
| DBID | AAYXX CITATION 7QJ 7X8 |
| DOI | 10.1016/j.jval.2020.01.022 |
| DatabaseName | CrossRef Applied Social Sciences Index & Abstracts (ASSIA) MEDLINE - Academic |
| DatabaseTitle | CrossRef Applied Social Sciences Index and Abstracts (ASSIA) MEDLINE - Academic |
| DatabaseTitleList | Applied Social Sciences Index and Abstracts (ASSIA) MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1524-4733 |
| EndPage | 767 |
| ExternalDocumentID | 10_1016_j_jval_2020_01_022 S1098301520301534 1_s2_0_S1098301520301534 |
| GroupedDBID | --- --K --M .1- .3N .FO .GA .Y3 .~1 0R~ 10A 123 1OC 1P~ 1~. 29Q 31~ 36B 4.4 44B 457 4G. 51W 51X 52N 52P 52R 52S 52X 53G 5LA 5VS 66C 6PF 7-5 7PT 8-1 8P~ 8UM AAEDT AAEDW AAFJI AAFWJ AAIKJ AAKOC AALRI AAMMB AAOAW AAPFB AAQFI AAQXK AATTM AAWTL AAXKI AAXUO AAYWO ABBQC ABCQN ABDBF ABEML ABIVO ABJNI ABMAC ABMMH ABMZM ABWVN ABXDB ACDAQ ACGFS ACHQT ACIEU ACLOT ACPRK ACRLP ACRPL ACUHS ACVFH ACXQS ADBBV ADCNI ADEZE ADFHU ADMUD ADNMO ADVLN AEBSH AEFGJ AEIPS AEKER AENEX AEUPX AEVXI AEXQZ AEYQN AFBPY AFEBI AFJKZ AFPUW AFRHN AFTJW AFXIZ AFZJQ AGHFR AGQPQ AGTHC AGUBO AGXDD AGYEJ AIDQK AIDYY AIEXJ AIGII AIIAU AIIUN AIKHN AITUG AJAOE AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX AOMHK APXCP ASPBG AVARZ AVWKF AXJTR AXLSJ AZFZN BAWUL BFHJK BKOJK BLXMC BNPGV BY8 CAG CO8 COF CS3 DCZOG DIK DU5 EAD EAP EBS EFJIC EFKBS EFLBG EJD EMB EMK EMOBN ESX F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN GBLVA HF~ HVGLF HZI HZ~ IHE IXB KOM LH4 M41 MO0 N9A O-L O9- OAUVE OIG OK1 OVD P-8 P-9 P2P PC. PQQKQ PRBVW Q38 QB0 R2- ROL SDF SEL SES SPCBC SSB SSF SSH SSO SSZ SV3 T5K TEORI TUS W99 WIN WYUIH XG1 YFH Z5R ~G- ~HD 0SF 6I. AACTN AAFTH AAHHS ABVKL ACCFJ AEEZP AEQDE AFCTW AFKWA AIWBW AJBDE AJOXV AMFUW NCXOZ RIG SUPJJ AAIAV ABLVK ABYKQ AJBFU AKYCK IXIXF LCYCR AAYXX ALUQN CITATION O8X 7QJ 7X8 |
| ID | FETCH-LOGICAL-c467t-c6f4265836c09b74beb2caeec7f9168e2c507ad134cab42bc867b1a011a09d7c3 |
| ISICitedReferencesCount | 22 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000540495000011&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1098-3015 1524-4733 |
| IngestDate | Thu Oct 02 07:06:22 EDT 2025 Sat Nov 08 23:50:06 EST 2025 Tue Nov 18 22:40:10 EST 2025 Sat Nov 29 07:03:50 EST 2025 Fri Feb 23 02:45:50 EST 2024 Tue Feb 25 19:59:22 EST 2025 Tue Oct 14 19:37:30 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 6 |
| Keywords | EQ-5D patient-reported outcomes preference-based measures Alzheimer’s disease dementia quality of life validation |
| Language | English |
| License | This article is made available under the Elsevier license. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c467t-c6f4265836c09b74beb2caeec7f9168e2c507ad134cab42bc867b1a011a09d7c3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 ObjectType-Undefined-3 |
| OpenAccessLink | https://www.clinicalkey.com/#!/content/1-s2.0-S1098301520301534 |
| PQID | 2433294451 |
| PQPubID | 105593 |
| PageCount | 8 |
| ParticipantIDs | proquest_miscellaneous_2414008255 proquest_journals_2433294451 crossref_citationtrail_10_1016_j_jval_2020_01_022 crossref_primary_10_1016_j_jval_2020_01_022 elsevier_sciencedirect_doi_10_1016_j_jval_2020_01_022 elsevier_clinicalkeyesjournals_1_s2_0_S1098301520301534 elsevier_clinicalkey_doi_10_1016_j_jval_2020_01_022 |
| PublicationCentury | 2000 |
| PublicationDate | 2020-06-01 |
| PublicationDateYYYYMMDD | 2020-06-01 |
| PublicationDate_xml | – month: 06 year: 2020 text: 2020-06-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Lawrenceville |
| PublicationPlace_xml | – name: Lawrenceville |
| PublicationTitle | Value in health |
| PublicationYear | 2020 |
| Publisher | Elsevier Inc Elsevier Science Ltd |
| Publisher_xml | – name: Elsevier Inc – name: Elsevier Science Ltd |
| References | Rabins, Black (bib12) 2007; 19 Robinson, Tang, Taylor (bib6) 2015; 350 Kunz (bib25) 2010; 19 Black, Rabins (bib5) 2010 Romhild, Fleischer, Meyer (bib7) 2018; 16 Prince, Albanese, Guerchet, Prina (bib1) 2014 Nguyen, Mulhern, Kularatna, Byrnes, Moyle, Comans (bib22) 2017; 15 Lawton (bib10) 1997; 11 Silberfeld, Rueda, Krahn, Naglie (bib30) 2002; 11 Greiner, Weijnen, Nieuwenhuizen (bib45) 2003; 4 Logsdon, Gibbons, McCurry, Teri (bib14) 2002; 64 George, Whitehouse (bib16) 2010; 58 Prince, Bryce, Albanese, Wimo, Ribeiro, Ferri (bib3) 2013; 9 Spector, Thorgrimsen, Woods (bib21) 2003; 183 EuroQol (bib44) 1990; 16 Ettema, Droes, de Lange, Ooms, Mellenbergh, Ribbe (bib9) 2005; 17 Bowling, Rowe, Adams (bib11) 2015; 19 Prince, Bryce, Ferri (bib4) 2011 Whitehouse, Rabins (bib13) 1992; 6 Cohen-Mansfield, Marx, Werner (bib40) 1992; 4 Hinkle, Wiersma, Jurs (bib46) 2003 Yesavage, Brink, Rose (bib41) 1982; 17 Li, Nguyen, Comans, Scuffham (bib33) 2018; 21 Ettema, Droes, de Lange, Mellenbergh, Ribbe (bib19) 2005; 14 Michalowsky, Kostev, Hoffmann, Bohlken (bib2) 2018; 51 Yang, Dawes, Leroi, Gannon (bib34) 2018; 33 Orgeta, Edwards, Hounsome, Orrell, Woods (bib32) 2015; 24 Aguirre, Kang, Hoare, Edwards, Orrell (bib31) 2016; 25 Sullivan, Slejko, Sculpher, Ghushchyan (bib26) 2011; 31 Naglie, Tomlinson, Tansey (bib29) 2006; 15 Zhao, Yue, Yang, Wang, Wu, Li (bib28) 2010; 13 Logsdon, Gibbons, McCurry, Teri (bib43) 1999; 5 Karlawish, Zbrozek, Kinosian (bib38) 2008; 4 Orrell, Aguirre, Spector (bib20) 2014; 204 Lawton, Brody (bib42) 1969; 9 Dichter, Schwab, Meyer, Bartholomeyczik, Halek (bib8) 2016; 70 Comans, Nguyen, Mulhern (bib23) 2018; 8 Johnson, Coons (bib47) 1998; 7 Moniz-Cook, Vernooij-Dassen, Woods (bib17) 2008; 12 Bryan, Hardyman, Bentham, Buckley, Laight (bib36) 2005; 14 Auer, Reisberg (bib39) 1997; 9 Hurst, Kind, Ruta, Hunter, Stubbings (bib48) 1997; 36 Oster, Willebrand, Dyster-Aas, Kildal, Ekselius (bib24) 2009; 35 Dichter, Wolschon, Schwab, Meyer, Kopke (bib50) 2018; 18 Diaz-Redondo, Rodriguez-Blazquez, Ayala (bib27) 2014; 14 Thorgrimsen, Selwood, Spector (bib15) 2003; 17 Sclan, Reisberg (bib49) 1992; 4 Arons, Krabbe, Scholzel-Dorenbos, van der Wilt, Rikkert (bib37) 2013; 13 Ready, Ott, Grace (bib18) 2004; 19 Hounsome, Orrell, Edwards (bib35) 2011; 14 Thorgrimsen (10.1016/j.jval.2020.01.022_bib15) 2003; 17 Bryan (10.1016/j.jval.2020.01.022_bib36) 2005; 14 Oster (10.1016/j.jval.2020.01.022_bib24) 2009; 35 Arons (10.1016/j.jval.2020.01.022_bib37) 2013; 13 Lawton (10.1016/j.jval.2020.01.022_bib42) 1969; 9 Diaz-Redondo (10.1016/j.jval.2020.01.022_bib27) 2014; 14 Naglie (10.1016/j.jval.2020.01.022_bib29) 2006; 15 Yesavage (10.1016/j.jval.2020.01.022_bib41) 1982; 17 Sclan (10.1016/j.jval.2020.01.022_bib49) 1992; 4 Aguirre (10.1016/j.jval.2020.01.022_bib31) 2016; 25 Greiner (10.1016/j.jval.2020.01.022_bib45) 2003; 4 Moniz-Cook (10.1016/j.jval.2020.01.022_bib17) 2008; 12 Hurst (10.1016/j.jval.2020.01.022_bib48) 1997; 36 Silberfeld (10.1016/j.jval.2020.01.022_bib30) 2002; 11 Michalowsky (10.1016/j.jval.2020.01.022_bib2) 2018; 51 Ettema (10.1016/j.jval.2020.01.022_bib9) 2005; 17 Ready (10.1016/j.jval.2020.01.022_bib18) 2004; 19 Hounsome (10.1016/j.jval.2020.01.022_bib35) 2011; 14 Zhao (10.1016/j.jval.2020.01.022_bib28) 2010; 13 Logsdon (10.1016/j.jval.2020.01.022_bib43) 1999; 5 Orgeta (10.1016/j.jval.2020.01.022_bib32) 2015; 24 George (10.1016/j.jval.2020.01.022_bib16) 2010; 58 Black (10.1016/j.jval.2020.01.022_bib5) 2010 Nguyen (10.1016/j.jval.2020.01.022_bib22) 2017; 15 Sullivan (10.1016/j.jval.2020.01.022_bib26) 2011; 31 Auer (10.1016/j.jval.2020.01.022_bib39) 1997; 9 Johnson (10.1016/j.jval.2020.01.022_bib47) 1998; 7 Dichter (10.1016/j.jval.2020.01.022_bib50) 2018; 18 Bowling (10.1016/j.jval.2020.01.022_bib11) 2015; 19 Karlawish (10.1016/j.jval.2020.01.022_bib38) 2008; 4 Robinson (10.1016/j.jval.2020.01.022_bib6) 2015; 350 Logsdon (10.1016/j.jval.2020.01.022_bib14) 2002; 64 Prince (10.1016/j.jval.2020.01.022_bib3) 2013; 9 Yang (10.1016/j.jval.2020.01.022_bib34) 2018; 33 Romhild (10.1016/j.jval.2020.01.022_bib7) 2018; 16 Li (10.1016/j.jval.2020.01.022_bib33) 2018; 21 Cohen-Mansfield (10.1016/j.jval.2020.01.022_bib40) 1992; 4 Lawton (10.1016/j.jval.2020.01.022_bib10) 1997; 11 Orrell (10.1016/j.jval.2020.01.022_bib20) 2014; 204 Prince (10.1016/j.jval.2020.01.022_bib1) 2014 Dichter (10.1016/j.jval.2020.01.022_bib8) 2016; 70 Whitehouse (10.1016/j.jval.2020.01.022_bib13) 1992; 6 Spector (10.1016/j.jval.2020.01.022_bib21) 2003; 183 Comans (10.1016/j.jval.2020.01.022_bib23) 2018; 8 Rabins (10.1016/j.jval.2020.01.022_bib12) 2007; 19 Prince (10.1016/j.jval.2020.01.022_bib4) 2011 Hinkle (10.1016/j.jval.2020.01.022_bib46) 2003 Kunz (10.1016/j.jval.2020.01.022_bib25) 2010; 19 EuroQol (10.1016/j.jval.2020.01.022_bib44) 1990; 16 Ettema (10.1016/j.jval.2020.01.022_bib19) 2005; 14 |
| References_xml | – volume: 58 start-page: 796 year: 2010 end-page: 797 ident: bib16 article-title: Intergenerational volunteering and quality of life for persons with mild-to-moderate dementia: results from a 5-month intervention study in the United States publication-title: J Am Geriatr Soc – volume: 4 start-page: 221 year: 1992 end-page: 240 ident: bib40 article-title: Agitation in elderly persons: an integrative report of findings in a nursing home publication-title: Int Psychogeriatr – volume: 204 start-page: 454 year: 2014 end-page: 461 ident: bib20 article-title: Maintenance cognitive stimulation therapy for dementia: single-blind, multicentre, pragmatic randomised controlled trial publication-title: Br J Psychiatry – volume: 5 start-page: 21 year: 1999 end-page: 32 ident: bib43 article-title: Quality of life in Alzheimer’s disease: patient and caregiver reports publication-title: J Ment Health Aging – volume: 4 start-page: 222 year: 2003 end-page: 231 ident: bib45 article-title: A single European currency for EQ-5D health states: results from a six-country study publication-title: Eur J Health Econ – volume: 13 start-page: 110 year: 2013 ident: bib37 article-title: Quality of life in dementia: a study on proxy bias publication-title: BMC Med Res Methodol – year: 2003 ident: bib46 article-title: Applied Statistics for the Behavioral Sciences – volume: 17 start-page: 353 year: 2005 end-page: 370 ident: bib9 article-title: The concept of quality of life in dementia in the different stages of the disease publication-title: Int Psychogeriatr – volume: 11 start-page: 91 year: 1997 end-page: 99 ident: bib10 article-title: Assessing quality of life in Alzheimer disease research publication-title: Alzheimer Disease Assoc Disord – volume: 25 start-page: 45 year: 2016 end-page: 49 ident: bib31 article-title: How does the EQ-5D perform when measuring quality of life in dementia against two other dementia-specific outcome measures? publication-title: Qual Life Res – volume: 21 start-page: 471 year: 2018 end-page: 481 ident: bib33 article-title: Utility-based instruments for people with dementia: a systematic review and meta-regression analysis publication-title: Value Health – volume: 183 start-page: 248 year: 2003 end-page: 254 ident: bib21 article-title: Efficacy of an evidence-based cognitive stimulation therapy programme for people with dementia: randomised controlled trial publication-title: Br J Psychiatry – volume: 17 start-page: 201 year: 2003 end-page: 208 ident: bib15 article-title: Whose quality of life is it anyway? The validity and reliability of the Quality of Life-Alzheimer’s Disease (QoL-AD) scale publication-title: Alzheimer Dis Assoc Disord – volume: 8 year: 2018 ident: bib23 article-title: Developing a dementia-specific preference--based quality of life measure (AD-5D) in Australia: a valuation study protocol publication-title: BMJ Open – year: 2014 ident: bib1 article-title: World Alzheimer Report 2014—Dementia and Risk Reduction, an Analysis of Protective and Modifiable Risk Factors – volume: 14 start-page: 107 year: 2005 end-page: 118 ident: bib36 article-title: Proxy completion of EQ-5D in patients with dementia publication-title: Qual Life Res – volume: 6 start-page: 135 year: 1992 end-page: 137 ident: bib13 article-title: Quality of life and dementia publication-title: Alzheimer Disease Assoc Disord – volume: 70 start-page: 233 year: 2016 end-page: 245 ident: bib8 article-title: Linguistic validation and reliability properties are weak investigated of most dementia-specific quality of life measurements-a systematic review publication-title: J Clin Epidemiol – volume: 64 start-page: 510 year: 2002 end-page: 519 ident: bib14 article-title: Assessing quality of life in older adults with cognitive impairment publication-title: Psychosom Med – volume: 31 start-page: 800 year: 2011 end-page: 804 ident: bib26 article-title: Catalogue of EQ-5D scores for the United Kingdom publication-title: Med Decis Making – start-page: 293 year: 2010 end-page: 304 ident: bib5 article-title: Quality of life in dementia: conceptual and practical issues publication-title: Dementia – volume: 11 start-page: 71 year: 2002 end-page: 79 ident: bib30 article-title: Content validity for dementia of three generic preference based health related quality of life instruments publication-title: Quality Life Res – volume: 9 start-page: 167 year: 1997 end-page: 171 ident: bib39 article-title: The GDS/FAST staging system publication-title: Int Psychogeriatr – volume: 14 start-page: 390 year: 2011 end-page: 399 ident: bib35 article-title: EQ-5D as a quality of life measure in people with dementia and their carers: evidence and key issues publication-title: Value Health – volume: 9 start-page: 63 year: 2013 end-page: 75.e62 ident: bib3 article-title: The global prevalence of dementia: a systematic review and metaanalysis publication-title: Alzheimers Demen – volume: 7 start-page: 155 year: 1998 end-page: 166 ident: bib47 article-title: Comparison of the EQ-5D and SF-12 in an adult US sample publication-title: Qual Life Res – volume: 19 start-page: 13 year: 2015 end-page: 31 ident: bib11 article-title: Quality of life in dementia: a systematically conducted narrative review of dementia-specific measurement scales publication-title: Aging Ment Health – volume: 18 start-page: 145 year: 2018 ident: bib50 article-title: Item distribution and inter-rater reliability of the German version of the quality of life in Alzheimer’s disease scale (QoL-AD) proxy for people with dementia living in nursing homes publication-title: BMC Geriatr – volume: 350 start-page: h3029 year: 2015 ident: bib6 article-title: Dementia: timely diagnosis and early intervention publication-title: BMJ – volume: 19 start-page: 425 year: 2010 end-page: 434 ident: bib25 article-title: Psychometric properties of the EQ-5D in a study of people with mild to moderate dementia publication-title: Qual Life Res – volume: 12 start-page: 14 year: 2008 end-page: 29 ident: bib17 article-title: A European consensus on outcome measures for psychosocial intervention research in dementia care publication-title: Aging Ment Health – volume: 14 start-page: 346 year: 2014 end-page: 353 ident: bib27 article-title: EQ-5D rated by proxy in institutionalized older adults with dementia: psychometric pros and cons publication-title: Geriatr Gerontol Int – volume: 15 start-page: 21 year: 2017 ident: bib22 article-title: Developing a dementia-specific health state classification system for a new preference-based instrument AD-5D publication-title: Health Qual Life Outcomes – volume: 4 start-page: 55 year: 1992 end-page: 69 ident: bib49 article-title: Functional Assessment Staging (FAST) in Alzheimer’s disease: reliability, validity, and ordinality publication-title: Int Psychogeriatr – volume: 19 start-page: 401 year: 2007 end-page: 407 ident: bib12 article-title: Measuring quality of life in dementia: purposes, goals, challenges and progress publication-title: Int Psychogeriatr – volume: 15 start-page: 631 year: 2006 end-page: 643 ident: bib29 article-title: Utility-based quality of life measures in Alzheimer’s disease publication-title: Qual Life Res – volume: 17 start-page: 37 year: 1982 end-page: 49 ident: bib41 article-title: Development and validation of a geriatric depression screening scale: a preliminary report publication-title: J Psychiatr Res – year: 2011 ident: bib4 article-title: World Alzheimer Report 2011: The Benefits of Early Diagnosis and Intervention – volume: 14 start-page: 675 year: 2005 end-page: 686 ident: bib19 article-title: A review of quality of life instruments used in dementia publication-title: Qual Life Res – volume: 16 start-page: 199 year: 1990 end-page: 208 ident: bib44 article-title: EuroQol—a new facility for the measurement of health-related quality of life publication-title: Health Policy – volume: 16 start-page: 131 year: 2018 ident: bib7 article-title: Inter-rater agreement of the Quality of Life-Alzheimer’s Disease (QoL-AD) self-rating and proxy rating scale: secondary analysis of RightTimePlaceCare data publication-title: Health Qual Life Outcomes – volume: 35 start-page: 723 year: 2009 end-page: 732 ident: bib24 article-title: Validation of the EQ-5D questionnaire in burn injured adults publication-title: Burns – volume: 51 start-page: 517 year: 2018 end-page: 522 ident: bib2 article-title: Indicators of an increase in dementia diagnosis rate in primary care [in German] publication-title: Zeitschrift fur Gerontologie und Geriatrie – volume: 13 start-page: 649 year: 2010 end-page: 656 ident: bib28 article-title: Validation and comparison of EuroQol and short form 6D in chronic prostatitis patients publication-title: Value Health – volume: 36 start-page: 551 year: 1997 end-page: 559 ident: bib48 article-title: Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D) publication-title: Br J Rheumatol – volume: 24 start-page: 315 year: 2015 end-page: 324 ident: bib32 article-title: The use of the EQ-5D as a measure of health-related quality of life in people with dementia and their carers publication-title: Qual Life Res – volume: 9 start-page: 179 year: 1969 end-page: 186 ident: bib42 article-title: Assessment of older people: self-maintaining and instrumental activities of daily living publication-title: Gerontologist – volume: 33 start-page: e166 year: 2018 end-page: e176 ident: bib34 article-title: Measurement tools of resource use and quality of life in clinical trials for dementia or cognitive impairment interventions: a systematically conducted narrative review publication-title: Int J Geriatr Psychiatry – volume: 19 start-page: 256 year: 2004 end-page: 265 ident: bib18 article-title: Patient versus informant perspectives of quality of life in mild cognitive impairment and Alzheimer’s disease publication-title: Int J Geriatr Psychiatry – volume: 4 start-page: 203 year: 2008 end-page: 211 ident: bib38 article-title: Caregivers’ assessments of preference-based quality of life in Alzheimer’s disease publication-title: Alzheimers Dement – volume: 14 start-page: 675 issue: 3 year: 2005 ident: 10.1016/j.jval.2020.01.022_bib19 article-title: A review of quality of life instruments used in dementia publication-title: Qual Life Res doi: 10.1007/s11136-004-1258-0 – volume: 64 start-page: 510 issue: 3 year: 2002 ident: 10.1016/j.jval.2020.01.022_bib14 article-title: Assessing quality of life in older adults with cognitive impairment publication-title: Psychosom Med doi: 10.1097/00006842-200205000-00016 – volume: 17 start-page: 37 issue: 1 year: 1982 ident: 10.1016/j.jval.2020.01.022_bib41 article-title: Development and validation of a geriatric depression screening scale: a preliminary report publication-title: J Psychiatr Res doi: 10.1016/0022-3956(82)90033-4 – start-page: 293 year: 2010 ident: 10.1016/j.jval.2020.01.022_bib5 article-title: Quality of life in dementia: conceptual and practical issues – volume: 16 start-page: 131 issue: 1 year: 2018 ident: 10.1016/j.jval.2020.01.022_bib7 article-title: Inter-rater agreement of the Quality of Life-Alzheimer’s Disease (QoL-AD) self-rating and proxy rating scale: secondary analysis of RightTimePlaceCare data publication-title: Health Qual Life Outcomes doi: 10.1186/s12955-018-0959-y – volume: 21 start-page: 471 issue: 4 year: 2018 ident: 10.1016/j.jval.2020.01.022_bib33 article-title: Utility-based instruments for people with dementia: a systematic review and meta-regression analysis publication-title: Value Health doi: 10.1016/j.jval.2017.09.005 – volume: 19 start-page: 256 issue: 3 year: 2004 ident: 10.1016/j.jval.2020.01.022_bib18 article-title: Patient versus informant perspectives of quality of life in mild cognitive impairment and Alzheimer’s disease publication-title: Int J Geriatr Psychiatry doi: 10.1002/gps.1075 – volume: 58 start-page: 796 issue: 4 year: 2010 ident: 10.1016/j.jval.2020.01.022_bib16 article-title: Intergenerational volunteering and quality of life for persons with mild-to-moderate dementia: results from a 5-month intervention study in the United States publication-title: J Am Geriatr Soc doi: 10.1111/j.1532-5415.2010.02790.x – volume: 7 start-page: 155 issue: 2 year: 1998 ident: 10.1016/j.jval.2020.01.022_bib47 article-title: Comparison of the EQ-5D and SF-12 in an adult US sample publication-title: Qual Life Res doi: 10.1023/A:1008809610703 – year: 2014 ident: 10.1016/j.jval.2020.01.022_bib1 – volume: 18 start-page: 145 issue: 1 year: 2018 ident: 10.1016/j.jval.2020.01.022_bib50 article-title: Item distribution and inter-rater reliability of the German version of the quality of life in Alzheimer’s disease scale (QoL-AD) proxy for people with dementia living in nursing homes publication-title: BMC Geriatr doi: 10.1186/s12877-018-0834-z – volume: 14 start-page: 107 issue: 1 year: 2005 ident: 10.1016/j.jval.2020.01.022_bib36 article-title: Proxy completion of EQ-5D in patients with dementia publication-title: Qual Life Res doi: 10.1007/s11136-004-1920-6 – volume: 24 start-page: 315 issue: 2 year: 2015 ident: 10.1016/j.jval.2020.01.022_bib32 article-title: The use of the EQ-5D as a measure of health-related quality of life in people with dementia and their carers publication-title: Qual Life Res doi: 10.1007/s11136-014-0770-0 – volume: 36 start-page: 551 issue: 5 year: 1997 ident: 10.1016/j.jval.2020.01.022_bib48 article-title: Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D) publication-title: Br J Rheumatol doi: 10.1093/rheumatology/36.5.551 – volume: 12 start-page: 14 issue: 1 year: 2008 ident: 10.1016/j.jval.2020.01.022_bib17 article-title: A European consensus on outcome measures for psychosocial intervention research in dementia care publication-title: Aging Ment Health doi: 10.1080/13607860801919850 – volume: 15 start-page: 631 issue: 4 year: 2006 ident: 10.1016/j.jval.2020.01.022_bib29 article-title: Utility-based quality of life measures in Alzheimer’s disease publication-title: Qual Life Res doi: 10.1007/s11136-005-4364-8 – volume: 19 start-page: 425 issue: 3 year: 2010 ident: 10.1016/j.jval.2020.01.022_bib25 article-title: Psychometric properties of the EQ-5D in a study of people with mild to moderate dementia publication-title: Qual Life Res doi: 10.1007/s11136-010-9600-1 – volume: 14 start-page: 346 issue: 2 year: 2014 ident: 10.1016/j.jval.2020.01.022_bib27 article-title: EQ-5D rated by proxy in institutionalized older adults with dementia: psychometric pros and cons publication-title: Geriatr Gerontol Int doi: 10.1111/ggi.12108 – volume: 35 start-page: 723 issue: 5 year: 2009 ident: 10.1016/j.jval.2020.01.022_bib24 article-title: Validation of the EQ-5D questionnaire in burn injured adults publication-title: Burns doi: 10.1016/j.burns.2008.11.007 – year: 2011 ident: 10.1016/j.jval.2020.01.022_bib4 – volume: 17 start-page: 353 issue: 3 year: 2005 ident: 10.1016/j.jval.2020.01.022_bib9 article-title: The concept of quality of life in dementia in the different stages of the disease publication-title: Int Psychogeriatr doi: 10.1017/S1041610205002073 – volume: 31 start-page: 800 issue: 6 year: 2011 ident: 10.1016/j.jval.2020.01.022_bib26 article-title: Catalogue of EQ-5D scores for the United Kingdom publication-title: Med Decis Making doi: 10.1177/0272989X11401031 – volume: 19 start-page: 401 issue: 3 year: 2007 ident: 10.1016/j.jval.2020.01.022_bib12 article-title: Measuring quality of life in dementia: purposes, goals, challenges and progress publication-title: Int Psychogeriatr doi: 10.1017/S1041610207004863 – volume: 13 start-page: 649 issue: 5 year: 2010 ident: 10.1016/j.jval.2020.01.022_bib28 article-title: Validation and comparison of EuroQol and short form 6D in chronic prostatitis patients publication-title: Value Health doi: 10.1111/j.1524-4733.2010.00728.x – volume: 15 start-page: 21 issue: 1 year: 2017 ident: 10.1016/j.jval.2020.01.022_bib22 article-title: Developing a dementia-specific health state classification system for a new preference-based instrument AD-5D publication-title: Health Qual Life Outcomes doi: 10.1186/s12955-017-0585-0 – volume: 51 start-page: 517 issue: 5 year: 2018 ident: 10.1016/j.jval.2020.01.022_bib2 article-title: Indicators of an increase in dementia diagnosis rate in primary care [in German] publication-title: Zeitschrift fur Gerontologie und Geriatrie doi: 10.1007/s00391-017-1336-x – volume: 9 start-page: 63 issue: 1 year: 2013 ident: 10.1016/j.jval.2020.01.022_bib3 article-title: The global prevalence of dementia: a systematic review and metaanalysis publication-title: Alzheimers Demen doi: 10.1016/j.jalz.2012.11.007 – volume: 14 start-page: 390 issue: 2 year: 2011 ident: 10.1016/j.jval.2020.01.022_bib35 article-title: EQ-5D as a quality of life measure in people with dementia and their carers: evidence and key issues publication-title: Value Health doi: 10.1016/j.jval.2010.08.002 – volume: 6 start-page: 135 issue: 3 year: 1992 ident: 10.1016/j.jval.2020.01.022_bib13 article-title: Quality of life and dementia publication-title: Alzheimer Disease Assoc Disord doi: 10.1097/00002093-199206030-00001 – volume: 183 start-page: 248 year: 2003 ident: 10.1016/j.jval.2020.01.022_bib21 article-title: Efficacy of an evidence-based cognitive stimulation therapy programme for people with dementia: randomised controlled trial publication-title: Br J Psychiatry doi: 10.1192/bjp.183.3.248 – volume: 33 start-page: e166 issue: 2 year: 2018 ident: 10.1016/j.jval.2020.01.022_bib34 article-title: Measurement tools of resource use and quality of life in clinical trials for dementia or cognitive impairment interventions: a systematically conducted narrative review publication-title: Int J Geriatr Psychiatry doi: 10.1002/gps.4771 – volume: 11 start-page: 71 issue: 1 year: 2002 ident: 10.1016/j.jval.2020.01.022_bib30 article-title: Content validity for dementia of three generic preference based health related quality of life instruments publication-title: Quality Life Res doi: 10.1023/A:1014406429385 – volume: 4 start-page: 55 issue: suppl 1 year: 1992 ident: 10.1016/j.jval.2020.01.022_bib49 article-title: Functional Assessment Staging (FAST) in Alzheimer’s disease: reliability, validity, and ordinality publication-title: Int Psychogeriatr doi: 10.1017/S1041610292001157 – volume: 5 start-page: 21 issue: 1 year: 1999 ident: 10.1016/j.jval.2020.01.022_bib43 article-title: Quality of life in Alzheimer’s disease: patient and caregiver reports publication-title: J Ment Health Aging – volume: 4 start-page: 221 issue: 2 year: 1992 ident: 10.1016/j.jval.2020.01.022_bib40 article-title: Agitation in elderly persons: an integrative report of findings in a nursing home publication-title: Int Psychogeriatr doi: 10.1017/S1041610292001285 – volume: 13 start-page: 110 year: 2013 ident: 10.1016/j.jval.2020.01.022_bib37 article-title: Quality of life in dementia: a study on proxy bias publication-title: BMC Med Res Methodol doi: 10.1186/1471-2288-13-110 – volume: 70 start-page: 233 year: 2016 ident: 10.1016/j.jval.2020.01.022_bib8 article-title: Linguistic validation and reliability properties are weak investigated of most dementia-specific quality of life measurements-a systematic review publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2015.08.002 – volume: 17 start-page: 201 issue: 4 year: 2003 ident: 10.1016/j.jval.2020.01.022_bib15 article-title: Whose quality of life is it anyway? The validity and reliability of the Quality of Life-Alzheimer’s Disease (QoL-AD) scale publication-title: Alzheimer Dis Assoc Disord doi: 10.1097/00002093-200310000-00002 – volume: 204 start-page: 454 issue: 6 year: 2014 ident: 10.1016/j.jval.2020.01.022_bib20 article-title: Maintenance cognitive stimulation therapy for dementia: single-blind, multicentre, pragmatic randomised controlled trial publication-title: Br J Psychiatry doi: 10.1192/bjp.bp.113.137414 – volume: 8 issue: 1 year: 2018 ident: 10.1016/j.jval.2020.01.022_bib23 article-title: Developing a dementia-specific preference--based quality of life measure (AD-5D) in Australia: a valuation study protocol publication-title: BMJ Open doi: 10.1136/bmjopen-2017-018996 – volume: 350 start-page: h3029 year: 2015 ident: 10.1016/j.jval.2020.01.022_bib6 article-title: Dementia: timely diagnosis and early intervention publication-title: BMJ doi: 10.1136/bmj.h3029 – volume: 25 start-page: 45 issue: 1 year: 2016 ident: 10.1016/j.jval.2020.01.022_bib31 article-title: How does the EQ-5D perform when measuring quality of life in dementia against two other dementia-specific outcome measures? publication-title: Qual Life Res doi: 10.1007/s11136-015-1065-9 – volume: 11 start-page: 91 issue: suppl 6 year: 1997 ident: 10.1016/j.jval.2020.01.022_bib10 article-title: Assessing quality of life in Alzheimer disease research publication-title: Alzheimer Disease Assoc Disord – volume: 4 start-page: 222 issue: 3 year: 2003 ident: 10.1016/j.jval.2020.01.022_bib45 article-title: A single European currency for EQ-5D health states: results from a six-country study publication-title: Eur J Health Econ doi: 10.1007/s10198-003-0182-5 – year: 2003 ident: 10.1016/j.jval.2020.01.022_bib46 – volume: 9 start-page: 167 issue: suppl 1 year: 1997 ident: 10.1016/j.jval.2020.01.022_bib39 article-title: The GDS/FAST staging system publication-title: Int Psychogeriatr doi: 10.1017/S1041610297004869 – volume: 19 start-page: 13 issue: 1 year: 2015 ident: 10.1016/j.jval.2020.01.022_bib11 article-title: Quality of life in dementia: a systematically conducted narrative review of dementia-specific measurement scales publication-title: Aging Ment Health doi: 10.1080/13607863.2014.915923 – volume: 4 start-page: 203 issue: 3 year: 2008 ident: 10.1016/j.jval.2020.01.022_bib38 article-title: Caregivers’ assessments of preference-based quality of life in Alzheimer’s disease publication-title: Alzheimers Dement doi: 10.1016/j.jalz.2007.11.018 – volume: 9 start-page: 179 issue: 3 part 1 year: 1969 ident: 10.1016/j.jval.2020.01.022_bib42 article-title: Assessment of older people: self-maintaining and instrumental activities of daily living publication-title: Gerontologist doi: 10.1093/geront/9.3_Part_1.179 – volume: 16 start-page: 199 issue: 3 year: 1990 ident: 10.1016/j.jval.2020.01.022_bib44 article-title: EuroQol—a new facility for the measurement of health-related quality of life publication-title: Health Policy doi: 10.1016/0168-8510(90)90421-9 |
| SSID | ssj0006325 |
| Score | 2.3891845 |
| Snippet | To assess the acceptability and validity of the 3 levels of the EQ-5D (EQ-5D-3L) compared with the Quality of Life in Alzheimer’s Diseases (QoL-AD) in patients... AbstractObjectivesTo assess the acceptability and validity of the 3 levels of the EQ-5D (EQ-5D-3L) compared with the Quality of Life in Alzheimer’s Diseases... Objectives To assess the acceptability and validity of the 3 levels of the EQ-5D (EQ-5D-3L) compared with the Quality of Life in Alzheimer's Diseases (QoL-AD)... To assess the acceptability and validity of the 3 levels of the EQ-5D (EQ-5D-3L) compared with the Quality of Life in Alzheimer's Diseases (QoL-AD) in patients... |
| SourceID | proquest crossref elsevier |
| SourceType | Aggregation Database Enrichment Source Index Database Publisher |
| StartPage | 760 |
| SubjectTerms | Acceptability Activities of daily living Alzheimer's disease Caregivers Convergent validity Dementia Dementia disorders EQ-5D Health Health services Health status Indexes Internal Medicine Neurodegenerative diseases Observational studies patient-reported outcomes Patients preference-based measures Quality of care Quality of life Ratings & rankings Regression analysis Response rates Self evaluation validation Validity Valuation methods |
| Title | Acceptability and Validity of the EQ-5D in Patients Living With Dementia |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1098301520301534 https://www.clinicalkey.es/playcontent/1-s2.0-S1098301520301534 https://dx.doi.org/10.1016/j.jval.2020.01.022 https://www.proquest.com/docview/2433294451 https://www.proquest.com/docview/2414008255 |
| Volume | 23 |
| WOSCitedRecordID | wos000540495000011&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVESC databaseName: Elsevier SD Freedom Collection Journals 2021 customDbUrl: eissn: 1524-4733 dateEnd: 20201231 omitProxy: false ssIdentifier: ssj0006325 issn: 1098-3015 databaseCode: AIEXJ dateStart: 20191101 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELe6DSFeEAwQ3cZkJLQXlilxPhw_FlY0kJiKKNA3y3Ec1qokU9OO7b_nHNtpu8H4kHiJqiSOU9_PvvPl7ncIvQhjCXokz71AwiSPCiE9wYim12aMFizLUyWaYhP09DQdjdig01m4XJiLKS3L9PKSnf9XUcM5ELZOnf0LcbcPhRPwG4QORxA7HP9I8D2pI1UM_bYhV_oMtnZuQy-0ndn_4MXH2tExMKSqNezMG7_CF-2UPW4chmOxarbCExYNu4hJm2ylpGPup9V364B9pWaly9LXl0fm2weMztd2Xa_Opt9sXeaV2KQmAKj5Zh_VlgG0OoPb1JpXgvjL6CnjKnPpMmvRnIEmL4UVJV5dfk26sYXZ6lpKTaEBq5apqdpxY8U3zofJ0QQkdaTfxLCwkqV-a6MOP-r-dfdE7wPjMNpAW4TGDNbzrd7b_uhdq8KTsKnW276vzbYygYHXe_qVRXNNtzcGy_ABum93GrhnEPIQdVS5je6-t7EU2-hgYFjLrw7xcJmEVx_iAzxY8plfPUIna4jCgCjsEIWrAgOicIMoPC6xQxQ2iMIaUdgh6jH69KY_fH3i2QIcngT9OfdkUoABF6dhIn2W0ShTGZFCKQmzOEhSRSTsJkQehJEUWUQymSY0CwSoDOGznMrwCdosq1I9RVjz1AkSKV8VKmI-YSIp8oIERRTDEGaqiwI3iFxadnpdJGXKXRjihOuB53rguR9waNVFL9s254ab5da7Qycb7rKOQU9yANKtrejPWqnazviaB7wm3Oc3wNVFcdvSWrPGSv1tj3sOOLzthGiaQabJBLvoeXsZNIH-vCdKVS30PUHUeHzinX_6q7vo3nIm76HN-WyhnqE78mI-rmf7aIOO0n07UX4AzEXXWQ |
| linkProvider | Elsevier |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Acceptability+and+Validity+of+the+EQ-5D+in+Patients+Living+With+Dementia&rft.jtitle=Value+in+health&rft.au=Michalowsky%2C+Bernhard&rft.au=Xie%2C+Feng&rft.au=Kohlmann%2C+Thomas&rft.au=Gr%C3%A4ske%2C+Johannes&rft.date=2020-06-01&rft.pub=Elsevier+Inc&rft.issn=1098-3015&rft.volume=23&rft.issue=6&rft.spage=760&rft.epage=767&rft_id=info:doi/10.1016%2Fj.jval.2020.01.022&rft.externalDocID=S1098301520301534 |
| thumbnail_m | http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F10983015%2FS1098301520X00088%2Fcov150h.gif |